FDA Readying Validation Guidance In Anticipation Of MDUFMA SUD Deadline
This article was originally published in The Gray Sheet
Executive Summary
The Medical Device User Fee & Modernization Act's effects on the bundling of multiple reprocessed single-use devices into one premarket submission will be among topics addressed in an upcoming guidance on validation data, according to FDA device center reps
You may also be interested in...
CDRH Bundling Policy Merits “Modest” Expansion – AdvaMed
Discrete premarket submissions should be required for reprocessed single-use devices made by different original equipment manufacturers, AdvaMed states in Jan. 22 comments on CDRH's "bundling" policy
CDRH Bundling Policy Merits “Modest” Expansion – AdvaMed
Discrete premarket submissions should be required for reprocessed single-use devices made by different original equipment manufacturers, AdvaMed states in Jan. 22 comments on CDRH's "bundling" policy
MedWatch Form To Include SUD Info; FDA Surveys Hospital Reprocessing
FDA will have to modify MedWatch forms to make reporting adverse events for reprocessed single-use devices easier, under a new reuse provision in the "Medical Device User Fee & Modernization Act.